These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38085062)

  • 1. Validation of PREDICT Version 2.2 in a Retrospective Cohort of Indian Women With Operable Breast Cancer.
    Nair NS; Kothari B; Gupta S; Kanann S; Vanmali V; Hawaldar R; Tondare A; Siddique S; Parmar V; Joshi S; Badwe RA
    JCO Glob Oncol; 2023 Sep; 9():e2300114. PubMed ID: 38085062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the online prediction tool PREDICT v. 2.0 in the Dutch breast cancer population.
    van Maaren MC; van Steenbeek CD; Pharoah PDP; Witteveen A; Sonke GS; Strobbe LJA; Poortmans PMP; Siesling S
    Eur J Cancer; 2017 Nov; 86():364-372. PubMed ID: 29100191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and survival of patients diagnosed with high-risk HR+/HER2- breast cancer in the Netherlands: a population-based retrospective cohort study.
    Lammers SWM; Meegdes M; Vriens IJH; Voogd AC; de Munck L; van Nijnatten TJA; Keymeulen KBMI; Tjan-Heijnen VCG; Geurts SME
    ESMO Open; 2024 May; 9(5):103008. PubMed ID: 38677006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
    Guan D; Jie Q; Wu Y; Xu Y; Hong W; Meng X
    World J Surg Oncol; 2022 Sep; 20(1):326. PubMed ID: 36175898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer.
    Miglietta F; Dieci MV; Tsvetkova V; Griguolo G; Vernaci G; Menichetti A; Faggioni G; Giarratano T; Mioranza E; Genovesi E; Cumerlato E; Bottosso M; Saibene T; Michieletto S; Lo Mele M; Conte P; Guarneri V
    Oncologist; 2020 Sep; 25(9):e1355-e1362. PubMed ID: 32618068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients.
    Zaguirre K; Kai M; Kubo M; Yamada M; Kurata K; Kawaji H; Kaneshiro K; Harada Y; Hayashi S; Shimazaki A; Morisaki T; Mori H; Oda Y; Chen S; Moriyama T; Shimizu S; Nakamura M
    Cancer Med; 2021 Mar; 10(5):1605-1613. PubMed ID: 33452761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential roles of lymphovascular space invasion based on tumor characteristics provide important prognostic information in T1 tumors with ER and HER2 positive breast cancer.
    Zhao Y; Yang N; Wang X; Huang Y; Zhou X; Zhang D
    Clin Transl Oncol; 2020 Dec; 22(12):2275-2285. PubMed ID: 32447641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.
    Martin M; Brase JC; Calvo L; Krappmann K; Ruiz-Borrego M; Fisch K; Ruiz A; Weber KE; Munarriz B; Petry C; Rodriguez CA; Kronenwett R; Crespo C; Alba E; Carrasco E; Casas M; Caballero R; Rodriguez-Lescure A
    Breast Cancer Res; 2014 Apr; 16(2):R38. PubMed ID: 24725534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer.
    Agostinetto E; Giordano L; Torrisi R; De Sanctis R; Masci G; Losurdo A; Zuradelli M; Tinterri C; Gatzemeier W; Testori A; Alloisio M; De Rose F; Fernandes B; Santoro A
    Clin Breast Cancer; 2020 Aug; 20(4):e481-e489. PubMed ID: 32279915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine sensitivity is decisive for patient outcome in small node-negative breast cancers (BC) (pT1a,b) - results from the Munich Cancer Registry.
    Kolben T; Harbeck N; Wuerstlein R; Schubert-Fritschle G; Bauerfeind I; Schrodi S; Engel J
    Breast; 2015 Feb; 24(1):24-31. PubMed ID: 25543874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of different lymph node staging systems in predicting prognosis and determining indications for postmastectomy radiotherapy in patients with T1-T2pN1 breast carcinoma.
    Kustić D; Klarica Gembić T; Grebić D; Petretić Majnarić S; Nekić J
    Strahlenther Onkol; 2020 Nov; 196(11):1044-1054. PubMed ID: 32710122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the PREDICT Prognostication Tool in US Patients With Breast Cancer.
    Stabellini N; Cao L; Towe CW; Miller ME; Sousa-Santos AH; Amin AL; Montero AJ
    J Natl Compr Canc Netw; 2023 Oct; 21(10):1011-1019.e6. PubMed ID: 37856198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of neoadjuvant therapy compared with adjuvant chemotherapy for the survival of patients with HER2-positive breast cancer: A retrospective cohort study at FUSCC.
    Zheng S; Li L; Chen M; Yang B; Chen J; Liu G; Shao Z; Wu J
    Breast; 2022 Jun; 63():177-186. PubMed ID: 35429731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy.
    Mougalian SS; Hernandez M; Lei X; Lynch S; Kuerer HM; Symmans WF; Theriault RL; Fornage BD; Hsu L; Buchholz TA; Sahin AA; Hunt KK; Yang WT; Hortobagyi GN; Valero V
    JAMA Oncol; 2016 Apr; 2(4):508-16. PubMed ID: 26720612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer.
    Sukumar JS; Sardesai S; Ni A; Williams N; Johnson K; Quiroga D; Ramaswamy B; Wesolowski R; Cherian M; Stover DG; Gatti-Mays M; Pariser A; Sudheendra P; George MA; Lustberg M
    Cancer Med; 2024 Jun; 13(12):e7317. PubMed ID: 38895891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
    Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P
    Lancet Oncol; 2020 Nov; 21(11):1455-1464. PubMed ID: 33152285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Features and Prognoses of Patients With Breast Cancer Who Underwent Surgery.
    Liu G; Kong X; Dai Q; Cheng H; Wang J; Gao J; Wang Y
    JAMA Netw Open; 2023 Aug; 6(8):e2331078. PubMed ID: 37624596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
    Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
    Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of adjuvant chemotherapy on T1N0M0 breast cancer patients: a propensity score matching study based on SEER database and external cohort.
    Shen K; Yao L; Zhu J; Gu X; Wang J; Qian W; Zheng Z; Fu D; Wu S
    BMC Cancer; 2022 Aug; 22(1):863. PubMed ID: 35941565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.